Retinal involvement in biopsy-proven dense deposit disease: A single-centre retrospective observational study
Open Access
- 1 January 2026
- journal article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in SCRIPTA MEDICA
- Vol. 57 (4) , 757-767
Abstract
Background/Aim: Dense deposit disease (DDD), formerly classified as membranoproliferative glomerulonephritis (MPGN) type II, is a rare renal disorder caused by dysregulation in the activation of the compliment system by an alternative pathway associated with retinal abnormalities. However, the frequency and spectrum of ocular involvement remain poorly defined because published evidence is limited to case reports and small case series. This study aimed to determine the frequency of retinal involvement among patients with biopsy-confirmed DDD identified within a consecutive MPGN cohort and to describe their clinical and multimodal retinal imaging findings. Methods: This retrospective observational study included all consecutive patients who underwent native kidney biopsy at the University Clinical Centre of the Republic of Srpska, Bosnia and Herzegovina, between 1 January 2021 and 31 March 2026. Patients with biopsy-confirmed MPGN underwent comprehensive ophthalmological examination, including multimodal retinal imaging. Clinical, histopathological and ophthalmological findings were analysed descriptively. Results: Among 110 native kidney biopsies, seven patients had MPGN, including three with biopsy-confirmed DDD. Retinal abnormalities were identified in two patients with DDD, whereas no ocular abnormalities were detected in other MPGN subtypes. One patient presented with acute exudative-ischaemic retinopathy showing partial anatomical and functional recovery, while the other exhibited the typical chronic drusenoid phenotype with drusen-like deposits, retinal pigment epithelium abnormalities and pigment epithelial detachments. Multimodal retinal imaging enabled detailed characterisation of retinal changes and choroidal neovascularisation was not detected. Conclusions: In this cohort, retinal involvement occurred exclusively in patients with biopsy-confirmed DDD and ranged from acute exudative-ischaemic retinopathy to the characteristic chronic drusenoid phenotype. These findings support comprehensive ophthalmological evaluation with multimodal retinal imaging in patients with DDD. Larger prospective multi-centre studies are needed to better define the prevalence, natural history and clinical significance of ocular involvement.Keywords
This publication has 25 references indexed in Scilit:
- Dense deposit disease complicated with choroidal neovascularizationEye, 2024
- Increased retinal drusen in IgA glomerulonephritis are further evidence for complement activation in disease pathogenesisScientific Reports, 2022
- C3 glomerulopathy: Understanding an ultra‐rare complement‐mediated renal diseaseAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2022
- Retinal drusen in glomerulonephritis with or without immune deposits suggest systemic complement activation in disease pathogenesisScientific Reports, 2022
- Retinal findings in glomerulonephritisClinical and Experimental Optometry, 2021
- C3 glomerulopathy — understanding a rare complement-driven renal diseaseNature Reviews Nephrology, 2019
- C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathyKidney International, 2018
- Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative GlomerulonephritisOphthalmology, 2016
- Dense Deposit Disease and C3 GlomerulopathySeminars in Nephrology, 2013
- Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesisEye, 2001